Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017 (2017), Article ID 2748614, 12 pages
https://doi.org/10.1155/2017/2748614
Research Article

The Immunogenicity of HLA Class II Mismatches: The Predicted Presentation of Nonself Allo-HLA-Derived Peptide by the HLA-DR Phenotype of the Recipient Is Associated with the Formation of DSA

Terasaki Foundation Laboratory, 11570 W Olympic Blvd., Los Angeles, CA 90064, USA

Correspondence should be addressed to Vadim Jucaud; gro.balikasaret@duacujv

Received 29 October 2016; Revised 17 January 2017; Accepted 2 February 2017; Published 26 February 2017

Academic Editor: Frans H. J. Claas

Copyright © 2017 Vadim Jucaud. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. I. Terasaki, “Humoral theory of transplantation,” American Journal of Transplantation, vol. 3, no. 6, pp. 665–673, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Pouliquen, A. Koenig, C. C. Chen et al., “Recent advances in renal transplantation: antibody-mediated rejection takes center stage,” F1000Prime Reports, vol. 7, article 51, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. E. J. Filippone and J. L. Farber, “Humoral immune response and allograft function in kidney transplantation,” American Journal of Kidney Diseases, vol. 66, no. 2, pp. 337–347, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Lachmann, P. I. Terasaki, K. Budde et al., “Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts,” Transplantation, vol. 87, no. 10, pp. 1505–1513, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. P. I. Terasaki and J. Cai, “Human leukocyte antigen antibodies and chronic rejection: from association to causation,” Transplantation, vol. 86, no. 3, pp. 377–383, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. F. H. J. Claas, M. K. Dankers, M. Oudshoorn et al., “Differential immunogenicity of HLA mismatches in clinical transplantation,” Transplant Immunology, vol. 14, no. 3-4, pp. 187–191, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. D. P. Lucas, M. S. Leffell, and A. A. Zachary, “Differences in immunogenicity of HLA antigens and the impact of cross-reactivity on the humoral response,” Transplantation, vol. 99, no. 1, pp. 77–85, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. M. J. Hickey, N. M. Valenzuela, and E. F. Reed, “Alloantibody generation and effector function following sensitization to human leukocyte antigen,” Frontiers in Immunology, vol. 7, article 30, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Koenig, C. Mariat, C. Mousson, K. J. Wood, G. Rifle, and O. Thaunat, “B cells and antibodies in transplantation,” Transplantation, vol. 100, no. 7, pp. 1460–1464, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Benichou, “Direct and indirect antigen recognition: the pathways to allograft immune rejection,” Frontiers in Bioscience: A Journal and Virtual Library, vol. 4, pp. D476–D480, 1999. View at Google Scholar · View at Scopus
  11. T. M. Conlon, K. Saeb-Parsy, J. L. Cole et al., “Germinal center alloantibody responses are mediated exclusively by indirect-pathway CD4 T follicular helper cells,” Journal of Immunology, vol. 188, no. 6, pp. 2643–2652, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. T. K. Starr, S. C. Jameson, and K. A. Hogquist, “Positive and negative selection of T cells,” Annual Review of Immunology, vol. 21, pp. 139–176, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. M. A. Daniels, E. Teixeiro, J. Gill et al., “Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling,” Nature, vol. 444, no. 7120, pp. 724–729, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. P. S. Heeger, “T-cell allorecognition and transplant rejection: a summary and update,” American Journal of Transplantation, vol. 3, no. 5, pp. 525–533, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Afzali, G. Lombardi, and R. I. Lechler, “Pathways of major histocompatibility complex allorecognition,” Current Opinion in Organ Transplantation, vol. 13, no. 4, pp. 438–444, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. N. R. Bennett, D. B. Zwick, A. H. Courtney, and L. L. Kiessling, “Multivalent antigens for promoting B and T cell activation,” ACS Chemical Biology, vol. 10, no. 8, pp. 1817–1824, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Geneugelijk, K. A. Thus, and E. Spierings, “Predicting alloreactivity in transplantation,” Journal of Immunology Research, vol. 2014, Article ID 159479, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. R. J. Duquesnoy, “HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm,” Human Immunology, vol. 63, no. 5, pp. 339–352, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Marrari and R. J. Duquesnoy, “Correlations between Terasaki's HLA class II epitopes and HLAMatchmaker-defined eplets on HLA-DR and -DQ antigens,” Tissue Antigens, vol. 74, no. 2, pp. 134–146, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. R. J. Duquesnoy, “HLA epitope based matching for transplantation,” Transplant Immunology, vol. 31, no. 1, pp. 1–6, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Wiebe, D. Pochinco, T. D. Blydt-Hansen et al., “Class II HLA epitope matching—a strategy to minimize de novo donor-specific antibody development and improve outcomes,” American Journal of Transplantation, vol. 13, no. 12, pp. 3114–3122, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. R. J. Duquesnoy, “Antibody-reactive epitope determination with HLAMatchmaker and its clinical applications,” Tissue Antigens, vol. 77, no. 6, pp. 525–534, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. M. K. A. Dankers, M. D. Witvliet, D. L. Roelen et al., “The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens,” Transplantation, vol. 77, no. 8, pp. 1236–1239, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. R. J. Duquesnoy and F. H. J. Claas, “14th international HLA and immunogenetics workshop: report on the structural basis of HLA compatibility,” Tissue Antigens, vol. 69, no. 1, pp. 180–184, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Kosmoliaptsis, L. D. Sharples, A. N. Chaudhry, D. J. Halsall, J. A. Bradley, and C. J. Taylor, “Predicting HLA class II alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms,” Transplantation, vol. 91, no. 2, pp. 183–190, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. V. Kosmoliaptsis, D. H. Mallon, Y. Chen, E. M. Bolton, J. A. Bradley, and C. J. Taylor, “Alloantibody responses after renal transplant failure can be better predicted by donor–recipient HLA amino acid sequence and physicochemical disparities than conventional HLA matching,” American Journal of Transplantation, vol. 16, no. 7, pp. 2139–2147, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. V. Kosmoliaptsis, T. R. Dafforn, A. N. Chaudhry, D. J. Halsall, J. A. Bradley, and C. J. Taylor, “High-resolution, three-dimensional modeling of human leukocyte antigen class I structure and surface electrostatic potential reveals the molecular basis for alloantibody binding epitopes,” Human Immunology, vol. 72, no. 11, pp. 1049–1059, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. V. Kosmoliaptsis, A. N. Chaudhry, L. D. Sharples et al., “Predicting HLA class i alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms,” Transplantation, vol. 88, no. 6, pp. 791–798, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. T. C. Fuller and A. Fuller, “The humoral immune response against an HLA class I allodeterminant correlates with the HLA-DR phenotype of the responder,” Transplantation, vol. 68, no. 2, pp. 173–182, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Maruya, N. Sasaki, N. El-Awar et al., “Immunogenic HLA class I epitopes identified by humoral response to pregnancies,” Clinical transplants, pp. 215–227, 2008. View at Google Scholar · View at Scopus
  31. A. R. Tambur and F. H. J. Claas, “HLA epitopes as viewed by antibodies: what is it all about?” American Journal of Transplantation, vol. 15, no. 5, pp. 1148–1154, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Andreatta, E. Karosiene, M. Rasmussen, A. Stryhn, S. Buus, and M. Nielsen, “Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification,” Immunogenetics, vol. 67, no. 11-12, pp. 641–650, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Zhang, Y. Chen, H.-S. Wong, S. Zhou, H. Mamitsuka, and S. Zhu, “TEPITOPEpan: extending TEPITOPE for peptide binding prediction covering over 700 HLA-DR molecules,” PLoS ONE, vol. 7, no. 2, Article ID e30483, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. H. G. Otten, J. J. A. Calis, C. Keşmir, A. D. van Zuilen, and E. Spierings, “Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation,” Human Immunology, vol. 74, no. 3, pp. 290–296, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Chaigne, K. Geneugelijk, B. Bédat et al., “Immunogenicity of anti-HLA antibodies in pancreas and islet transplantation,” Cell Transplantation, vol. 25, no. 11, pp. 2041–2050, 2016. View at Publisher · View at Google Scholar
  36. K. Geneugelijk, G. Hönger, H. W. M. van Deutekom et al., “Predicted indirectly recognizable HLA epitopes presented by HLA-DRB1 are related to HLA antibody formation during pregnancy,” American Journal of Transplantation, vol. 15, no. 12, pp. 3112–3122, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. R. J. Duquesnoy, “The antibody response to HLA mismatch: putting together the pieces of a puzzle,” American Journal of Transplantation, vol. 15, no. 12, pp. 3019–3020, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. N. El-Awar, A. Nguyen, K. Almeshari et al., “HLA class II DQA and DQB epitopes: recognition of the likely binding sites of HLA-DQ alloantibodies eluted from recombinant HLA-DQ single antigen cell lines,” Human Immunology, vol. 74, no. 9, pp. 1141–1152, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. R. J. Duquesnoy and M. Askar, “HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP,” Human Immunology, vol. 68, no. 1, pp. 12–25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. R. J. Duquesnoy, “A structurally based approach to determine HLA compatibility at the humoral immune level,” Human Immunology, vol. 67, no. 11, pp. 847–862, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Robinson, J. A. Halliwell, J. D. Hayhurst, P. Flicek, P. Parham, and S. G. E. Marsh, “The IPD and IMGT/HLA database: allele variant databases,” Nucleic Acids Research, vol. 43, no. 1, pp. D423–D431, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. A. R. Tambur, J. R. Leventhal, J. J. Friedewald, and D. S. Ramon, “The complexity of human leukocyte antigen (HLA)-DQ antibodies and its effect on virtual crossmatching,” Transplantation, vol. 90, no. 10, pp. 1117–1124, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. A. R. Tambur, J. R. Leventhal, J. R. Zitzner, R. C. Walsh, and J. J. Friedewald, “The DQ barrier: improving organ allocation equity using HLA-DQ information,” Transplantation, vol. 95, no. 4, pp. 635–640, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Armas-González, A. Díaz-Martín, M. J. Domínguez-Luis et al., “Differential antigen-presenting B cell phenotypes from synovial microenvironment of patients with rheumatoid and psoriatic arthritis,” Journal of Rheumatology, vol. 42, no. 10, pp. 1825–1834, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Nielsen, O. Lund, S. Buus, and C. Lundegaard, “MHC Class II epitope predictive algorithms,” Immunology, vol. 130, no. 3, pp. 319–328, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. H.-G. Rammensee, T. Friede, and S. Stevanović, “MHC ligands and peptide motifs: first listing,” Immunogenetics, vol. 41, no. 4, pp. 178–228, 1995. View at Publisher · View at Google Scholar · View at Scopus
  47. N. J. Felix and P. M. Allen, “Specificity of T-cell alloreactivity,” Nature Reviews Immunology, vol. 7, no. 12, pp. 942–953, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Chen, Y. Li, F. R. Depontieu et al., “Structure-based design of altered MHC class II-restricted peptide ligands with heterogeneous immunogenicity,” Journal of Immunology, vol. 191, no. 10, pp. 5097–5106, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Neefjes, M. L. M. Jongsma, P. Paul, and O. Bakke, “Towards a systems understanding of MHC class i and MHC class II antigen presentation,” Nature Reviews Immunology, vol. 11, no. 12, pp. 823–836, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Appelqvist, P. Wäster, K. Kågedal, and K. Öllinger, “The lysosome: from waste bag to potential therapeutic target,” Journal of Molecular Cell Biology, vol. 5, no. 4, pp. 214–226, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Watts, “The endosome-lysosome pathway and information generation in the immune system,” Biochimica et Biophysica Acta—Proteins and Proteomics, vol. 1824, no. 1, pp. 14–21, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. J. A. Villadangos, R. A. R. Bryant, J. Deussing et al., “Proteases involved in MHC dass II antigen presentation,” Immunological Reviews, vol. 172, no. 1, pp. 109–120, 1999. View at Publisher · View at Google Scholar · View at Scopus
  53. T. Burster, H. MacMillan, T. Hou et al., “Masking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules,” Immunology, vol. 130, no. 3, pp. 436–446, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. R. D. Bremel and E. J. Homan, “An integrated approach to epitope analysis II: a system for proteomic-scale prediction of immunological characteristics,” Immunome Research, vol. 6, no. 1, article 8, pp. 1–21, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. H.-G. Rammensee, J. Bachmann, N. P. N. Emmerich, O. A. Bachor, and S. Stevanović, “SYFPEITHI: database for MHC ligands and peptide motifs,” Immunogenetics, vol. 50, no. 3-4, pp. 213–219, 1999. View at Publisher · View at Google Scholar · View at Scopus
  56. C. X. Moss, J. A. Villadangos, and C. Watts, “Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing,” European Journal of Immunology, vol. 35, no. 12, pp. 3442–3451, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. L. Delamarre, R. Couture, I. Mellman, and E. S. Trombetta, “Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis,” Journal of Experimental Medicine, vol. 203, no. 9, pp. 2049–2055, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Sette, A. Vitiello, B. Reherman et al., “The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes,” Journal of Immunology, vol. 153, no. 12, pp. 5586–5592, 1994. View at Google Scholar · View at Scopus
  59. S. H. Van Der Burg, M. J. W. Visseren, R. M. P. Brandt, W. M. Kast, and C. J. M. Melief, “Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability,” Journal of Immunology, vol. 156, no. 9, pp. 3308–3314, 1996. View at Google Scholar · View at Scopus